- Home
- HRMY vs TIGR Comparison
HRMY vs TIGR Comparison
Compare HRMY & TIGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRMY
- TIGR
- Stock Information
- Founded
- HRMY 2017
- TIGR 2014
- Country
- HRMY United States
- TIGR Singapore
- Employees
- HRMY N/A
- TIGR N/A
- Industry
- HRMY Biotechnology: Pharmaceutical Preparations
- TIGR Investment Bankers/Brokers/Service
- Sector
- HRMY Health Care
- TIGR Finance
- Exchange
- HRMY Nasdaq
- TIGR Nasdaq
- Market Cap
- HRMY 2.1B
- TIGR 2.3B
- IPO Year
- HRMY 2020
- TIGR 2019
- Fundamental
- Price
- HRMY $32.29
- TIGR $10.85
- Analyst Decision
- HRMY Strong Buy
- TIGR Strong Buy
- Analyst Count
- HRMY 9
- TIGR 2
- Target Price
- HRMY $55.33
- TIGR $10.79
- AVG Volume (30 Days)
- HRMY 678.1K
- TIGR 7.1M
- Earning Date
- HRMY 10-28-2025
- TIGR 11-11-2025
- Dividend Yield
- HRMY N/A
- TIGR N/A
- EPS Growth
- HRMY 58.41
- TIGR 305.45
- EPS
- HRMY 3.10
- TIGR 0.66
- Revenue
- HRMY $772,527,000.00
- TIGR $421,673,984.00
- Revenue This Year
- HRMY $20.09
- TIGR $53.82
- Revenue Next Year
- HRMY $16.86
- TIGR $13.18
- P/E Ratio
- HRMY $10.42
- TIGR $16.99
- Revenue Growth
- HRMY 17.74
- TIGR 68.66
- 52 Week Low
- HRMY $26.47
- TIGR $3.39
- 52 Week High
- HRMY $41.61
- TIGR $14.48
- Technical
- Relative Strength Index (RSI)
- HRMY 30.41
- TIGR 44.07
- Support Level
- HRMY $31.61
- TIGR $10.96
- Resistance Level
- HRMY $37.05
- TIGR $11.51
- Average True Range (ATR)
- HRMY 1.18
- TIGR 0.82
- MACD
- HRMY -0.59
- TIGR -0.24
- Stochastic Oscillator
- HRMY 10.19
- TIGR 4.81
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
About TIGR UP Fintech Holding Ltd representing fifteen
UP Fintech Holding Ltd is an online brokerage firm focusing on Chinese investors. Its trading platform enables investors to trade in equities and other financial instruments on multiple exchanges of stocks and other derivatives. The company offers its customers brokerage and value-added services, including trade order placement and execution, margin financing, account management, investor education, community discussion, and customer support.